← Back to Search

Device

Bright Light Therapy for Frailty in Older Veterans (Brite-VET Trial)

N/A
Recruiting
Led By Bruce R. Troen, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to endpoint at 12 weeks

Summary

This trial will study whether bright light therapy can reduce frailty, improve sleep & cognitive function in older Veterans.

Who is the study for?
This trial is for older veterans who may be frail and have early-stage health issues. It's open to both men and women living in the community, but not those who are very overweight, without sleep problems, or with severe illnesses or cognitive impairments.
What is being tested?
The study tests Bright Light Therapy using AYO Glasses to see if they can help reduce frailty and improve cognition and sleep quality in elderly veterans by resynchronizing their biological clocks.
What are the potential side effects?
Bright Light Therapy is generally safe but could potentially cause eye strain or headache. Since it involves light exposure, there might also be a risk of disrupted sleep patterns if used improperly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to endpoint at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to endpoint at 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Amyloid beta 42/40 ratio
Anxiety and depression
Brain Derived Neurotrophic Factor (BDNF)
+16 more
Secondary study objectives
Body Composition (Lean and fat mass)
Frailty assessment
Gait speed
+2 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: BLT interventionActive Control1 Intervention
Bright light glasses that emit a more intense therapeutic blue light.
Group II: BLT controlPlacebo Group1 Intervention
Bright light glasses that emit a non-therapeutic blue light.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,663 Previous Clinical Trials
3,427,253 Total Patients Enrolled
Bruce R. Troen, MDPrincipal InvestigatorKansas City VA Medical Center, Kansas City, MO
2 Previous Clinical Trials
242 Total Patients Enrolled

Media Library

AYO Glasses (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05631236 — N/A
Elderly Veteran Research Study Groups: BLT control, BLT intervention
Elderly Veteran Clinical Trial 2023: AYO Glasses Highlights & Side Effects. Trial Name: NCT05631236 — N/A
AYO Glasses (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05631236 — N/A
~3 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top